responses to car t-cell therapy still strong after one year in patients with refractory nhl
Published 6 years ago • 281 plays • Length 6:59Download video MP4
Download video MP3
Similar videos
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma
-
8:50
an update of car t-cell therapies in lymphoma
-
2:11
the role of car-t therapy for lymphoma in 2024: expert session highlights
-
5:52
chimeric antigen receptor (car) / car-t
-
2:49
identifying novel antigens for tcr t-cell therapy
-
7:38
bernadette’s last hope for beating cancer: will car-t cell therapy cure her non-hodgkin's lymphoma?
-
6:24
results of the transcend study of car t cell product jcar017 in patients with r/r aggressive b-nhl
-
3:58
zuma-1: a pivotal trial of car t-cells in nhl
-
3:44
allohsct for r/r lbcl after car-t therapy failure
-
1:55
developing the next generation of car-t cells
-
3:01
phase 1 trial of car t-cell therapy for lymphoma
-
1:49
car-t cell approaches in cll: current progress & future directions
-
3:50
updates in the management of car-t toxicities
-
2:30
the future of car t-cell therapy
-
1:39
the role of myeloid cells in car-t cell therapy
-
3:04
car t-cell therapy for b-cell lymphomas: a focus on improving cr
-
2:08
the future of car t-cell therapy in lymphoma
-
3:21
safety management of car-t cell therapy in dlbcl
-
1:20
cd79b-specific car t-cell therapy: overcoming treatment resistance in b-cell lymphoma
-
1:47
car t-cell development in europe – where are we in cll?